FHJVX
Price
$44.31
Change
-$0.25 (-0.56%)
Updated
Nov 19 closing price
Net Assets
928.62M
VEUSX
Price
$98.56
Change
-$0.52 (-0.52%)
Updated
Nov 19 closing price
Net Assets
35.25B
Interact to see
Advertisement

FHJVX vs VEUSX

Header iconFHJVX vs VEUSX Comparison
Open Charts FHJVX vs VEUSXBanner chart's image
Fidelity Advisor Europe M
Price$44.31
Change-$0.25 (-0.56%)
VolumeN/A
Net Assets928.62M
Vanguard European Stock Admiral
Price$98.56
Change-$0.52 (-0.52%)
VolumeN/A
Net Assets35.25B
FHJVX vs VEUSX Comparison Chart in %
View a ticker or compare two or three
VS
FHJVX vs. VEUSX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHJVX is a Hold and VEUSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEUSX has more cash in the bank: 35.3B vs. FHJVX (929M). VEUSX pays higher dividends than FHJVX: VEUSX (2.88) vs FHJVX (2.04). FHJVX was incepted earlier than VEUSX: FHJVX (12 years) vs VEUSX (24 years). FHJVX (1.17) is less costly to investors than VEUSX (0.08). FHJVX is a more actively managed with annual turnover of: 31.00 vs. VEUSX (3.00). FHJVX has a lower initial minimum investment than VEUSX: FHJVX (0) vs VEUSX (3000). FHJVX annual gain was more profitable for investors over the last year : 28.36 vs. VEUSX (22.55). VEUSX return over 5 years is better than : 38.91 vs. FHJVX (18.37).
FHJVXVEUSXFHJVX / VEUSX
Total Expense Ratio1.170.081,462%
Annual Report Gross Expense Ratio1.170.081,462%
Fund Existence12 years24 years-
Gain YTD28.08324.862113%
Front Load4%N/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets929M35.3B3%
Annual Yield % from dividends2.042.8871%
Returns for 1 year28.3622.55126%
Returns for 3 years53.2744.76119%
Returns for 5 years18.3738.9147%
Returns for 10 years30.2959.2451%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARQT27.890.61
+2.24%
Arcutis Biotherapeutics
SINT3.360.06
+1.82%
SiNtx Technologies Inc.
FSLR251.87-0.32
-0.13%
First Solar
AQST5.83-0.08
-1.35%
Aquestive Therapeutics
FRD19.88-0.38
-1.88%
Friedman Industries Inc